A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular marker and signature molecule.
Researchers at New Jersey Institute of Technology in collaboration with Ohio University and Merck & Co. Inc. recently developed a new efficient method for targeted protein analysis -- one they say could speed up processes for disease testing, drug discovery and vaccine development.
Johns Hopkins Kimmel Cancer Center researchers from the Department of Radiation Oncology and Molecular Radiation Sciences identified a lipid-regulating protein that conveys what the researchers describe as "superpowers" onto prostate cancer cells, causing them to aggressively spread.
Published recently in the Stem Cells journal, a new study addresses a major issue that has been challenging the human mesenchymal stem cells (hMSCs) therapy.
Chandra Mohan, a Hugh Roy and Lillie Cranz Cullen Endowed Professor of biomedical engineering at the University of Houston, and his colleagues have identified a race-specific variance in the urinary biomarker proteins of lupus nephritis (LN) in patients.
Scientists are increasingly aiming to leverage the various functions of lipids in human bodies, for example, in blood coagulation or as blood fats, to better interpret and predict a host of diseases.
Women who don't survive a rare and aggressive uterine cancer called uterine serous carcinoma, have high expression of a group of 73 genes, a score scientists say can help identify these women and improve their outcome.
Researchers from the Center for Precision Disease Modeling at the University of Maryland School of Medicine have uncovered a mechanism that appears to explain how certain genetic mutations give rise to a rare genetic kidney disorder called nephrotic syndrome.
NanoMosaic LLC intends to commercialize a high-throughput, high-sensitivity platform for analyte detection developed at Harvard University.
Researchers discovered that high blood levels of RNA produced by the PHGDH gene could serve as a biomarker for early detection of Alzheimer's disease.
Researchers led by Isabel Gordo have captured, in real time, the occurrence of spurts of diversity in the microbiota, which is induced by bacterial cells that have mutation rates analogous to cancer cells.
At the Chalmers University of Technology, scientists have demonstrated that the Atox1 protein, which is highly concentrated in breast cancer cells, takes part in a process—the process through which cancer cells spread.
A team of scientists has recently outlined the need to develop and standardize lipidomic measurements and baseline figures.
A recent study has revealed that the expression of long noncoding RNA LINC00426 is related to prognosis for non‐small cell lung cancer.
A team has revealed the existence of viable biomarkers of ovarian cancer by investigating the profiles of circular RNA expression.